GALDERMA LABORATORIES, L.P. v. TEVA PHARMACEUTICALS USA, INC.

Civil Action No. 3:17-cv-01076-M.

GALDERMA LABORATORIES, L.P., GALDERMA S.A., and NESTLÉ SKIN HEALTH S.A., Plaintiffs, v. TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICALS INDUSTRIES LTD., Defendants.

United States District Court, N.D. Texas, Dallas Division.

November 17, 2017.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 830 Property Rights: Patent
Source: PACER


Attorney(s) appearing for the Case

Galderma Laboratories LP, Plaintiff, represented by Jamil N. Alibhai , Munck Wilson Mandala LLP.

Galderma Laboratories LP, Plaintiff, represented by Daniel E. Venglarik , Munck Wilson Mandala LLP, Jordan Christine Strauss , Munck Wilson Mandala LLP, Kelly P. Chen , Munck Wilson Mandala LLP & Michael C. Wilson , Munck Wilson Mandala LLP.

Galderma SA, Plaintiff, represented by Jamil N. Alibhai , Munck Wilson Mandala LLP, Daniel E. Venglarik , Munck Wilson Mandala LLP, Jordan Christine Strauss , Munck Wilson Mandala LLP, Kelly P. Chen , Munck Wilson Mandala LLP & Michael C. Wilson , Munck Wilson Mandala LLP.

Nestle Skin Health SA, Plaintiff, represented by Jamil N. Alibhai , Munck Wilson Mandala LLP, Daniel E. Venglarik , Munck Wilson Mandala LLP, Jordan Christine Strauss , Munck Wilson Mandala LLP, Kelly P. Chen , Munck Wilson Mandala LLP & Michael C. Wilson , Munck Wilson Mandala LLP.

Actavis Laboratories UT Inc, Defendant, represented by Leora Ben-Ami , Kirkland and Ellis LLP, pro hac vice, Scott W. Breedlove , Carter Scholer Arnett Mockler, E. Leon Carter , Carter Scholer Arnett Hamada & Mockler PLLC & Thomas F. Fleming , Kirkland and Ellis LLP, pro hac vice.

TEVA Pharmaceuticals USA Inc, Defendant, represented by Leora Ben-Ami , Kirkland and Ellis LLP, pro hac vice, Scott W. Breedlove , Carter Scholer Arnett Mockler, E. Leon Carter , Carter Scholer Arnett Hamada & Mockler PLLC & Thomas F. Fleming , Kirkland and Ellis LLP, pro hac vice.


MEMORANDUM OPINION AND ORDER

Before the Court are (1) a Rule 12(b)(3) motion to dismiss for improper venue [ECF #21], filed by Defendant Teva Pharmaceuticals USA, Inc. ("Teva USA") [ECF #21]; and (2) a Rule 12(b)(6) motion to dismiss for failure to state a claim [ECF #25]...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases